Standard Labs sells research peptides exclusively to qualified researchers and laboratories for in vitro and laboratory use. Please confirm before continuing.
By proceeding you affirm the statements above are true. Products are not for human or veterinary use, not for use in diagnostic procedures, and have not been evaluated by the U.S. Food and Drug Administration.
Eighteen compounds are discussed for appetite, blood sugar and weight. This guide reads each one the same way: what the study measured, what it found, and where the evidence stops.
A 20% weight-loss headline can mean total weight, fat mass, or a number from a scan study. Every profile says which one — and whether the work was in people, in mice, or in a forum post. No grades, no dosing advice.
Not a ranking and not a protocol. Every profile runs the same questions, so two compounds can be read side by side without one getting a better edit than the other.
A scale adds up fat, water, muscle and other tissue. A scan can separate fat from the rest. A blood test measures sugar. The guide names the measure before the number, because “weight loss” is not one thing.
The result, the comparison and the time frame — stated together. In SURMOUNT-1 at week 72, average weight loss on the 15 mg arm was 20.9% against 3.1% on placebo. The number means something because the arm and the week are attached.
Some profiles rest on mice. One 536-person trial found no clear weight-loss difference from placebo. Amounts reported in forums are printed as unverified, not as instructions. Interactions are often unknown, and the profile says so.
Plus: an 18-name index, six biology questions, a 25-term glossary, a one-page method for reading metabolic research, and the sources behind every profile.
The guide groups research questions rather than ranking compounds. The grouping is a reading aid — not an evidence score, not a treatment category, and not a statement that any of them is safe for human use.
Tirzepatide · Semaglutide · Retatrutide · Orforglipron
Cagrilintide · Eloralintide
CagriSema · Zenagamtide · VK2735 · EloraTZP · UBT251
AOD-9604 · GHRP-6 · MK-677
Follistatin 344 · PEG-MGF · IGF-1 LR3
5-Amino-1-MQ
The groups overlap. A compound can sit in more than one research question, and the guide says so rather than forcing one label.
This one separates what a trial measured from what a forum post noticed. It keeps the comparison group, the week count and the study type attached to the number — and where the work was in mice, it says mice. A trial result is not a recommendation.
You have seen a 20% figure and want to know whether it was total weight, fat mass or blood sugar — and whether it came from a 72-week human trial or an 11-day mouse study.
You want a dose, a stack or a promise. Trial doses are study groups, forum amounts are unverified, and the guide does not tell you what to use.
Enter your email and we'll send the 30-page PDF. Then a short series on the distinction that decides most metabolic claims: what was measured, and in whom.
One email, then the 30-page PDF.
We sent a confirmation link to the email you entered. Click it and the guide will arrive.
Nothing in 5 minutes? Check spam, or contact us.
Open the peptide calculatorAdults reading about metabolic research — appetite, blood sugar, weight and body composition — who want the evidence and the limits in the same place. No lab background is assumed. It is not a clinical manual, a protocol, or a review of Canadian approval status.
Yes. The PDF is free. We ask for your email so we can send it, confirm your consent and follow up with a short series on reading a metabolic claim. You can unsubscribe at any time.
No. The guide is educational material for research. It does not tell you what to take, and it does not replace a licensed healthcare provider. Some compounds discussed are prescription medicines in Canada. Products referenced are supplied for laboratory research use only.
No. Where a trial assigned doses, those are printed as study groups, not recommendations. Amounts reported in forums are marked unverified. No compound is graded strong, moderate or weak.
Because they arrived without a study, a test group, a date or a named author. Reprinting a number is not the same as validating it, so every number is printed with its status attached.
A reading map, six biology questions, an 18-name index, 18 compound profiles, a 25-term glossary, a one-page method for reading metabolic research, and the sources behind each profile.
Because a no-difference result is part of the evidence. AOD-9604 is the clearest example: a 536-person oral study reviewed by the FDA found no clear weight-loss difference from placebo at 12 weeks. Leaving that out would make the rest of the guide less honest, not more useful.
Some of them are in the Canadian research catalogue. The guide is not a ranking of what we stock, and a catalogue listing does not validate any claim about a compound.
A confirmation, the guide, then a short series over a few days. After that, occasional research updates. Every email has a one-click unsubscribe.
No. We do not sell or share your email with third parties. The form stores your name, email, interest and consent record so we can honour your preferences.
Reading about focus, memory or sleep instead? Read the free 39-page nootropics guide.
New to research peptides altogether? Start with the 51-page beginner’s guide.
Researching muscle, recovery or aging? Read the Muscle Growth & Recovery Guide or The Longevity Guide.